维普中文期刊产品整合服务
18篇 您的检索式:作者名="CARMOSINO I"
    题名 作者 年代 出处 被引量
1Early and tardive skin adverse events in chronic myeloid leukaemia patients treated with imatinib显示文摘Breccia M Carmosino I Russo E 2005Eur J Haematol2005,74,:1
2Early detection of meningeal localization in acute promyelocytic leukemia pa- tients with high presenting leucocyte count显示文摘Breccia M Carmosino I Dverio D 2003Br J Haema- tol2003,120,2:1
3Early detection of meningeal localization in acute promyelocytic leukaemia patients with high presentingleucocyte count显示文摘Breccia M Carmosino I Diverio D 2003BrJ Haematol2003,120,2:1
4Acute myelogenous leukemia in elderly patients not eligible for intensive chemotherapy:the dark side of the moon显示文摘Latagliata R Bongarzoni V Carmosino I 2006Ann Oncol2006,17,2:1
5Clinical and biological features of acute promyelocytic leukemia patients developing retinoic acid syndrome during induction treatment with all-trans retinoic acid and idarubicin显示文摘Breccia M Latagliata R Carmosino I 0,,12:1
6Usefulness and prognostic impact on survival of WHO reclassification in FAB low risk myelodyplastic syndromes 显示文摘Breccia M Carmosino I Biondo F 2006Leuk Res2006,30,:1
7'Real-life'results of frontline treatment with Imatinib in older patients(≥years)with newly diagnosed chronic myelogenous leukemia显示文摘Latagliata R Breccia M Carmosino I 2010Leuk Res2010,34,11:1
8Acute myelogenous leukemia in elderly patients not eligible for intensive chemotherapy:the dark side of the moon显示文摘Latagliata R Bongarzoni V Carmosino I 2006Ann Oncol2006,17,2:1
9Arsenic trioxide in the treatment of advanced acute promyelocytic leukemia显示文摘CARMOSINO I LATAGLIATA R AVVISATI G 2004Haematologica2004,89,5:1
10Usefulness and prognostic impact on survival of WHO reclassification in FAB low risk myelodyplastic syndromes显示文摘Breccia M Carmosino I Biondo F 2006Leuk Res2006,30,2:1
11'Real-life'results of frontline treatment with imatinib in older patients(≥65 years)with newly diagnosed chronicmyelogenous leukemia显示文摘Latagliata R Breccia M Carmosino I 2010Leuk Res2010,34,11:1
12Usefulness and prognostic impact on survival of WHO reclassification in FAB low risk myelodyplastic syndromes显示文摘BRECCIA M CARMOSINO I BIONDO F 2005Leuk Res2005,,:1
13Early detection of meningeal localization in acute promyelocytic leukemia patients with high presenting leucocyte count显示文摘Breccia M Carmosino I Dverio D 2003Br J Haematol2003,,:1
14Conservative treatment for patients over 80 years witli acute myelogenous leukemia显示文摘LATAGLIATA R ALIMENA G CARMOSINO I 2002Am J Hematol2002,71,:1
15Late relapse(>5years from diagnosis)in acute promyelocytic leukemia(acute promyelocytic leukemia)显示文摘Latagliata R Breccia M Carmosino I 2005Haematologica Reports2005,1,:1
16Arsenic trioxide in the treatment of advanced acute promyebcytic leukemia 显示文摘Carmosino I Latagliata R Avvisati G 2004Haematologica2004,89,5:1
17Arsenic trioxide in the treatment of advanced acute promyelocytic leukemia 显示文摘Carmosino I Latagliata R Avvisati G 2004Haematologica2004,89,:1
18Clinico-pathological characteristics of myeloid sarcoma at diagnosis and during follow-up : report of 12 eases from a single institution显示文摘Breccia M Pescarmona E Carmosino I 2004Leuk Res2004,28,11:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费